Federal Executive Order: Enhancing Access to Medical Marijuana in Medicare
Discover how recent federal changes will expand Medicare access to hemp-derived cannabinoid products and the implications for the insurance industry.
CMS Proposes Medicare Coverage for Legal CBD Amid Regulatory Uncertainty
CMS proposes Medicare coverage for federally and state-legal CBD products, highlighting evolving regulatory approaches amid clinical evidence and hemp legislation conflicts.
CMS Proposes Medicare Coverage for Hemp-Derived CBD Products
CMS proposes new Medicare rule to cover hemp-derived CBD products compliant with federal and state law, expanding treatment options for seniors and impacting healthcare costs.
CMS Proposes Medicare Coverage for CBD Products Under New Regulatory Framework
CMS updates Medicare Advantage policy to allow insurance coverage for federally and state-legal CBD products, amid evolving hemp regulatory definitions and market challenges.